A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention

Catheter Cardiovasc Interv. 2021 Aug 1;98(2):197-205. doi: 10.1002/ccd.29176. Epub 2020 Aug 14.

Abstract

Background: Reliable preprocedural risk scores for the prediction of Contrast-Induced Acute Kidney Injury (CI-AKI) following Percutaneous Coronary Intervention (pPCI) in patients with ST-elevation myocardial infarction (STEMI) are lacking. Aim of this study was to derive and validate a preprocedural Risk Score in this setting.

Methods: Two prospectively enrolled patient cohorts were used for derivation and validation (n = 3,736). CI-AKI was defined as creatinine increase ≥0.5 mg/dl <72 h postpPCI. Odds ratios from multivariable logistic regression model were converted to an integer, whose sum represented the Risk Score.

Results: Independent CI-AKI predictors were: diabetes, Killip class II-III (2 points each), age > 75 years, anterior MI (3 points), Killip class IV (4 points), estimated GFR < 60 ml/min/1.73m2 (5 points). The Risk Score c-statistic was 0.84 in both cohorts. Compared with patients with Risk Score ≤ 4, the relative risks of CI-AKI among patients scoring 5-9 were 6.2 (derivation cohort) and 7.1 (validation cohort); among patients scoring ≥10, 19.8, and 21.4, respectively.

Conclusions: Among STEMI patients, a simple preprocedural Risk Score accurately and reproducibly predicted the risk of CI-AKI, identifying ¼ of patients with a seven-fold risk and 1/10 of patients with a 20-fold risk. This knowledge may help tailored strategies, including delaying revascularization of nonculprit vessels in patients at high risk of CI-AKI.

Keywords: acute ST elevation myocardial infarction; acute kidney injury; contrast medium; prognosis.

MeSH terms

  • Acute Kidney Injury* / chemically induced
  • Acute Kidney Injury* / diagnosis
  • Acute Kidney Injury* / epidemiology
  • Aged
  • Contrast Media
  • Creatinine
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • ST Elevation Myocardial Infarction* / diagnostic imaging
  • Treatment Outcome

Substances

  • Contrast Media
  • Creatinine